newsfilter
← Latest News
GlobeNewswire·

Leading Independent Proxy Advisory Firm ISS Recommends Strongbridge Biopharma plc Shareholders Vote "FOR" the Transaction With Xeris

DUBLIN, Ireland and TREVOSE, Pa., Aug. 30, 2021 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (NASDAQ:SBBP) ("Strongbridge") today announced that the leading independent proxy advisory firm Institutional Shareholder Services ("ISS") has recommended